Evidence map›Paper›PMID 35393710›Full record

ArticleDermatologic therapy2022

COVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine.

Irene López Riquelme, María Dolores Fernández Ballesteros, Ana Serrano Ordoñez, Daniel Jesús Godoy Díaz

Abstract readLetter
In one paragraph

Article in Dermatologic therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Exposome Risk Factors for Vitiligo: A Systematic Evidence Review.American journal of clinical dermatology · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.Clinical, cosmetic and investigational dermatology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Irene López RiquelmeDermatology Department, Hospital Regional Universitario de Málaga, Málaga, Spain.ORCID 0000-0002-6488-4381
María Dolores Fernández BallesterosDermatology Department, Hospital Regional Universitario de Málaga, Málaga, Spain.
Ana Serrano OrdoñezDermatology Department, Hospital Regional Universitario de Málaga, Málaga, Spain.
Daniel Jesús Godoy DíazDermatology Department, Hospital Regional Universitario de Málaga, Málaga, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Autoimmune DiseasesCOVID-19HypopigmentationVaccinesVitiligoHumansVaccines

Identifiers

PMID35393710
PMCPMC9111626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.